These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23065657)

  • 1. RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma.
    Tennstedt P; Fresow R; Simon R; Marx A; Terracciano L; Petersen C; Sauter G; Dikomey E; Borgmann K
    Int J Cancer; 2013 May; 132(9):2118-26. PubMed ID: 23065657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of H2Bub1 Expression is Linked to Poor Prognosis in Nodal Negative Colorectal Cancers.
    Melling N; Grimm N; Simon R; Stahl P; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
    Pathol Oncol Res; 2016 Jan; 22(1):95-102. PubMed ID: 26347467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
    Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
    Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.
    Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
    J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
    Koelzer VH; Huber B; Mele V; Iezzi G; Trippel M; Karamitopoulou E; Zlobec I; Lugli A
    Hum Pathol; 2015 Nov; 46(11):1573-81. PubMed ID: 26351067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
    Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
    Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
    Cheah PY; Choo PH; Yao J; Eu KW; Seow-Choen F
    Cancer; 2002 Dec; 95(12):2479-86. PubMed ID: 12467060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients.
    Li Y; Wang WY; Xiao JH; Xu F; Liao DY; Xie L; Wang J; Luo F
    PLoS One; 2017; 12(1):e0167868. PubMed ID: 28099437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
    Ozawa T; Kazama S; Akiyoshi T; Murono K; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Morikawa T; Fukayama M; Watanabe T
    Ann Surg Oncol; 2014 Aug; 21(8):2650-8. PubMed ID: 24728738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
    Boltze C
    Pathol Res Pract; 2005; 200(11-12):783-90. PubMed ID: 15792121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
    Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
    Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
    Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.
    Zlobec I; Vuong T; Hayashi S; Haegert D; Tornillo L; Terracciano L; Lugli A; Jass J
    Br J Cancer; 2007 Mar; 96(5):793-800. PubMed ID: 17311026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of HLA class I expression in patients with colorectal cancer.
    Iwayama Y; Tsuruma T; Mizuguchi T; Furuhata T; Toyota N; Matsumura M; Torigoe T; Sato N; Hirata K
    World J Surg Oncol; 2015 Feb; 13():36. PubMed ID: 25889416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.
    Hur H; Kim YB; Ham IH; Lee D
    J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.